Semaglutide and skin sensitivity: what's actually happening

You've just injected your first dose, and your skin looks different

Picture this: it's the morning after your first Wegovy injection. You glance at the site on your thigh and there's a small red patch, slightly raised and a little warm to touch. You're not sure whether to be concerned or just carry on. For most people in this position, what they're seeing is a normal localised injection-site reaction, your skin responding to the needle, the preservatives in the solution, or simply the unfamiliar process of subcutaneous injection. The NHS notes injection-site reactions as a common side effect of semaglutide, and they appear in this pattern precisely because a foreign substance has been deposited under the skin.

These localised reactions typically settle within a day or two. Rotating injection sites (abdomen, upper thigh, upper arm) across each weekly dose reduces the chance of one area becoming repeatedly irritated. If the redness spreads well beyond the injection point, feels hot over a wider area, or doesn't fade within 48 hours, that warrants a call to your prescriber rather than a wait-and-see approach. You can read a fuller picture of how semaglutide affects the skin more broadly, including less common presentations.

When the sensitivity isn't just at the injection site

A smaller group of people taking semaglutide for weight management report skin sensitivity away from the injection point, generalised itching, a flushed or tender feeling across wider areas, or a rash that appears somewhere unrelated to where the pen was used. If you're wondering whether sensitive skin is a recognised side effect of Wegovy, the answer involves looking at both the medicine's direct action and the physical changes that come with significant weight loss. The honest answer is that it can be both.

Semaglutide itself is a GLP-1 receptor agonist, and GLP-1 receptors are present in skin tissue; there is plausible biology behind the medicine influencing skin sensation. At the same time, the rapid change in body weight and composition that effective treatment produces can alter skin texture, elasticity, and sensitivity to temperature, fabric, and pressure in ways that have nothing to do with the drug's direct action. Distinguishing between these causes matters, because the management differs. The full side-effect profile of semaglutide covers both the common GI effects and the skin-related patterns, which is worth reading alongside this page.

Urticaria (hives) and rash are listed in the Wegovy SmPC as uncommon effects. If you develop hives or notice itching that's persistent and widespread rather than localised, your prescriber needs to know, not because it's necessarily dangerous, but because they need to rule out a true allergic response and consider whether any dose adjustment or pause is appropriate.

When to get medical help, and what can't wait

Most skin sensitivity associated with semaglutide treatment is manageable and self-limiting. There are, however, signs that require prompt medical attention rather than a conversation booked for next week. Swelling of the face, lips, tongue, or throat; difficulty breathing or swallowing; a sudden widespread rash accompanied by dizziness, these are potential signs of a serious allergic reaction and need emergency care immediately.

A more gradual but still clinically important scenario is persistent itching that doesn't settle between doses, particularly if accompanied by jaundice (yellowing of the skin or whites of the eyes). This can be a signal of gallbladder or liver involvement, which the MHRA and the NHS medicines page for semaglutide each flag as something to take seriously. Gallbladder problems (including gallstones) are a recognised risk with rapid weight loss and have been reported in semaglutide trials.

There is also the question of pancreatitis: severe, persistent stomach pain that radiates to the back should not be attributed to skin sensitivity and needs the same urgent response as the allergic signs above. If you're uncertain whether your situation counts as pancreatitis risk, the detail at our page on Wegovy and pancreatitis history may help clarify what to discuss with a clinician.

For any suspected side effect (whether skin-related or otherwise) the Yellow Card scheme at yellowcard.mhra.gov.uk lets you report directly to the MHRA. It exists precisely because post-market surveillance of medicines like Wegovy depends on real-world reports from patients, not only clinical trials.

What to do if you're experiencing skin changes right now

If your skin is reacting and you're unsure what to do next, the practical first step is to keep a brief note: where on your body, when it started relative to your last injection, how it looks and feels, and whether it's getting better or worse. That information, shared with a prescriber, transforms a vague concern into something actionable. Our clinical team, detailed on the prescribers page, includes GPhC-registered Independent Prescribers who field exactly these kinds of questions through our aftercare service, seven days a week.

Some people find that a mild topical antihistamine eases localised injection-site itching in the short term, but this should be confirmed as appropriate for you by your prescriber before you use it, particularly if you are taking other regular medicines. Don't stop your semaglutide dose without clinical guidance; abrupt discontinuation isn't clinically indicated for a mild localised skin reaction, and restarting after a gap can itself cause GI side effects.

If you're still in the process of deciding whether treatment is right for you, our Wegovy overview covers the broader context of how the medicine works, who it's licensed for, and what the clinical evidence shows. Specific itching patterns are covered in more detail at our itchy skin and semaglutide page. And for anyone exploring their options more broadly, our weight-loss treatment overview sets out all the licensed approaches available through nume, skin concerns and full medical history included in that initial conversation at no charge.